TCRX short interest
TScan Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 2,486,277 |
|---|---|
| Change vs prior report | 206,114 (+9.0%) |
| Change over six months | +31.9% |
| Days to cover | 3.25 (sector: 3.78) |
| Average daily volume | 764,430 |
| Rank in Healthcare | #603 of 922 by days to cover |
TCRX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,486,277 | +9.0% | 3.25 | 764,430 |
| 2026-09-15 | 2,280,163 | +30.3% | 1.16 | 1,966,155 |
| 2026-08-31 | 1,749,828 | +9.3% | 6.97 | 250,997 |
| 2026-08-14 | 1,601,066 | +2.7% | 4.24 | 377,894 |
| 2026-07-31 | 1,558,905 | +12.6% | 2.78 | 560,685 |
| 2026-07-15 | 1,384,530 | +95.5% | 1.19 | 1,160,818 |
| 2026-06-30 | 708,200 | -7.1% | 1.00 | 782,925 |
| 2026-06-15 | 762,526 | -18.4% | 1.94 | 392,390 |
| 2026-05-29 | 934,310 | +6.6% | 2.04 | 457,592 |
| 2026-05-15 | 876,559 | +0.7% | 1.04 | 840,606 |
| 2026-04-30 | 870,161 | -7.7% | 1.00 | 1,098,631 |
| 2026-04-15 | 942,877 | -50.0% | 1.00 | 1,566,620 |
| 2026-03-31 | 1,885,270 | -0.4% | 3.77 | 500,400 |
| 2026-03-13 | 1,892,903 | -1.9% | 2.69 | 702,720 |
| 2026-02-27 | 1,930,510 | -3.7% | 4.51 | 428,150 |
| 2026-02-13 | 2,003,903 | -21.9% | 4.35 | 460,887 |
| 2026-01-30 | 2,566,263 | +8.7% | 5.29 | 485,094 |
| 2026-01-15 | 2,360,339 | +13.6% | 4.25 | 555,924 |
| 2025-12-31 | 2,077,294 | -18.2% | 3.32 | 625,472 |
| 2025-12-15 | 2,539,912 | +8.7% | 3.27 | 775,729 |
| 2025-11-28 | 2,335,680 | +19.8% | 2.75 | 850,678 |
| 2025-11-14 | 1,949,768 | +11.9% | 1.45 | 1,348,069 |
| 2025-10-31 | 1,742,176 | +4.0% | 3.06 | 569,461 |
| 2025-10-15 | 1,675,616 | +6.9% | 1.75 | 959,807 |
| 2025-09-30 | 1,567,792 | -9.0% | 5.65 | 277,361 |
import finzdata as yf
yf.Ticker("TCRX").short_interest # every report since 2017
yf.Client().short_interest(["TCRX"], start="2018-01-01")Healthcare short interest · TCRX price history · Who owns TCRX · All short interest